InvestorsHub Logo
Followers 38
Posts 5017
Boards Moderated 2
Alias Born 08/05/2002

Re: bwonder post# 3657

Tuesday, 10/14/2014 9:56:13 PM

Tuesday, October 14, 2014 9:56:13 PM

Post# of 9139
BWonder,

They are at the mercy of their partners. They are developing products, but need cash to market.Dahl did more in two years than Howard did in 10 years.

Spot on. Baer did nothing but line his pockets first, just like he is still doing today ..... And still hasn't produced anything.

Reality is HEPI has always needed cash to make this happen. It appears HEPI is building a quality board with biotech and animal health executive experience. The preliminary data Dahl showed in the slides looks quite interesting. The letter says HEPI is very happy with the results. The question is whether Zoetis is happy with the results. The Dairy Experts in Tulare CA are ZTS' hand picked CRO. Nice to know.

Wellmetris moving along slowly. Still think they should be selling part of this to JV partner who could finish the work and launch it. Taking too long on this.

And then there's this reverse split mention. Almost always negative connotation. Seen it work. Seen it fail more often then not. My opinion is that Dahl has probably come to the conclusion that real investors aren't going to buy a 12 cent stock. I am guessing that Masterson and her institutional contacts wouldn't finance at these prices either and that's probably the first thing she said coming in. If it was private, probably another story. But given price and structure, a tough sell. I'd have to see what the potential plan is on a reverse split and whether a deal coincides with it. IMO it would have to include bringing in real investors that actually understand what investing in biotech entails.

Amigo Mike

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ZIVO News